Novo Nordisk's
ORG · 6 article mentions
Recent mentions
- New data boosts our confidence in Lilly's obesity pill. Plus, Google's new AI features
- 'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
- Amazon to carry Ozempic pill at U.S. kiosks, offer same-day delivery
- What's behind Eli Lilly's down-and-up day after last week's post-earnings surge
- Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance
- More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says